These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1279830)

  • 1. [Dalargin in the therapy of the exacerbations of chronic pancreatitis].
    Geller LI; Kazakevich VV; Pashko MM
    Ter Arkh; 1992; 64(8):80-2. PubMed ID: 1279830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enteral correction of homeostasis in acute pancreatitis].
    Penin VA; Emel'ianov SI; Rybakov GS; Koval'skaia KS; Strusov VV; Zhuravleva GM
    Khirurgiia (Mosk); 1996; (2):8-11. PubMed ID: 8754889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of several regulatory peptides on the functional activity of the pancreas in acute experimental pancreatitis].
    Grigorevskiĭ VP; Korotkina RN; Karelin AA
    Biull Eksp Biol Med; 1989 Oct; 108(10):428-30. PubMed ID: 2597753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of dalargin in the treatment of acute cholecystopancreatitis complicated by obstructive jaundice].
    Skomarovskiĭ ATs; Zemskov VS; Skomarovskiĭ AA
    Klin Khir; 1996; (8):13-4. PubMed ID: 9064131
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of synthetic neuropeptides in complex of surgical treatment of acute pancreatitis and its complication].
    Pobuts'kyĭ OO
    Klin Khir; 2002 Jan; (1):26-9. PubMed ID: 11944292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of the effect of kontrikal, 5-fluorouracil and the new Soviet peptide preparation dalargin on the course of experimental pancreonecrosis].
    Georgadze AK; Permiakov NK; Penin VA; Titov MI; Titova GP
    Farmakol Toksikol; 1986; 49(6):66-70. PubMed ID: 2434356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphofunctional changes in the pancreas in response to dalargin under normal conditions and in experimental pancreatitis].
    Kurzanov AN; Titova GP; Vinogradov VA; Aleĭnik VA; Gerasimov NF
    Biull Eksp Biol Med; 1988 Apr; 105(4):445-7. PubMed ID: 3359026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of patients with chronic pancreatitis of alcoholic etiology by dalagrin and laser therapy of the blood].
    Bulychev VF; Vakhrushev IaM
    Klin Med (Mosk); 2000; 78(12):43-6. PubMed ID: 11210353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dalargin--the first enkephalin analog, used in gastroenterology].
    Vinogradov VA; Polonskiĭ VM
    Ter Arkh; 1988; 60(8):147-53. PubMed ID: 3067406
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of synthetic analogs of L-enkephalin on viable areas of the pancreas in experimental pancreatitis].
    Kanaian AS; Permiakov NK; Titova GP; Gabrielian NA; Voskanian LO
    Biull Eksp Biol Med; 1988 Apr; 105(4):447-51. PubMed ID: 3359027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of an analog of endogenous opioids, dalargin, on the structure and function of the exocrine tissue of the pancreas in experimental acute pancreatitis].
    Georgadze AK; Permiakov NK; Vinogradov VA; Penin VA; Titova GP
    Farmakol Toksikol; 1985; 48(5):101-4. PubMed ID: 2416590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The synthetic leu-enkephalin--dalargin--in the therapy of the irritable bowel syndrome and chronic noninfectious undefined colitis].
    Smishchuk IuO
    Lik Sprava; 1998 Jun; (4):93-6. PubMed ID: 9784715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dalargin in the prevention of acute postoperative pancreatitis].
    Grigorevskiĭ VP; Korotkina RN; Pomelov VS; Shloznikov BM; Karelin AA
    Klin Khir (1962); 1989; (11):9-12. PubMed ID: 2640568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of regulator peptides on pancreatic endocrine function in experimental acute pancreatitis].
    Tsvirkun VV; Grigorevskiĭ VP; Botsmanov KV; Bocharova VS
    Biull Eksp Biol Med; 1989 Dec; 108(12):748-51. PubMed ID: 2576773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Features of diagnosis and treatment of fatty pancreatic necrosis].
    Georgadze AK; Buzenkov SV; Dzhikia AA; Karpov VI
    Khirurgiia (Mosk); 1991 Apr; (4):90-5. PubMed ID: 2062078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of dalargin for treating duodenal peptic ulcer recurrences on an outpatient basis].
    Buglak NP; Grigorenko EI; Dudar' LV
    Lik Sprava; 1994; (7-8):121-3. PubMed ID: 7900332
    [No Abstract]   [Full Text] [Related]  

  • 17. [The significance of trypsin, amylase and lipase activities in the blood serum for the differential,diagnosis of chronic pancreatitis and other diseases of the abdominal organs].
    Geller LI; Pashko MM
    Vrach Delo; 1990 Mar; (3):86-8. PubMed ID: 1695041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylaxis of pancreatogenic disturbances by infusion of monomer-electrolyte solutions combined with dalargin].
    Koval'skaia KS; Emel'ianov SI
    Biull Eksp Biol Med; 1998 Oct; 126(10):401-4. PubMed ID: 9825135
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transcranial electrostimulation combined with dalargin ultraphonophoresis in the treatment of patients with chronic idiopathic eczema].
    Iakushkina NIu; Silina LV; Zav'ialov AV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2005; (4):25-7. PubMed ID: 16149414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of dalargin on the course of mechanical trauma].
    Sherman DM
    Klin Khir (1962); 1992; (9-10):28-30. PubMed ID: 1291773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.